ISSN: 2375-3005
American Journal of Microbiology and Biotechnology  
Manuscript Information
 
 
Occurrence of Beta-Lactamases and the Antibiogram Pattern of Clinical Isolates of Escherichia coli and Klebsiella Species in Nsukka Metropolis
American Journal of Microbiology and Biotechnology
Vol.2 , No. 5, Publication Date: Aug. 20, 2015, Page: 69-74
1753 Views Since August 20, 2015, 1810 Downloads Since Aug. 20, 2015
 
 
Authors
 
[1]    

Eze E. A., Department of Microbiology, University of Nigeria, Nsukka, Nigeria.

[2]    

Agbo E. C., Department of Microbiology, University of Nigeria, Nsukka, Nigeria.

[3]    

Eze C. N., Department of Microbiology, University of Nigeria, Nsukka, Nigeria.

 
Abstract
 

Infections due to β-Lactamases producing Escherichia coliand Klebsiella species are increasingly recognized in recent years. They are creating clinical concerns. This is because few antibiotics are available as therapeutic options. A total of 113 screened isolates of E.coli and Klebsiella spp obtained from November 2013 to December 2014 from various clinical specimens such as urine, stool, sputum, wound swab and high vaginal swab (HVS) were included in this study. All isolates were identified and confirmed by standard methods. Isolates were screened for β- lactamase and extended spectrum beta- lactamases (ESBLs) using Nitrocefin test and Double disk synergy detection test. All confirmed β-lactamases producing isolates were tested for susceptibility to ten different antibiotics by disk diffusion method. The overall prevalence of 51(45.1%) and 33(27.2%) were recorded for β-lactamases and ESBLs production respectively. E.coli showed higher prevalence (47%, 30.3%) followed by Klebseilla species (42.7%, 27.7%) for β-lactamase and ESBLs respectively. Age distribution of β-lactamse producing isolates among patients showed highest prevalence (68.4%) among 41-50 years age group. ESBL producers were 50.0% of the organisms isolated from individuals 51years and above. Both β- lactamase and ESBLs producers were susceptible to Imipenem and Nitrofuration and resistant to Ampicilin, Augmentin and the cephalosporins. This study indicates that β-lactamase producers are widely distributed in the study area. This poses public health challenges.


Keywords
 

Prevalence, Eschericia coli, Klebsiella spp, β- lactamase Producers, ESBLs Producers, Antibiotics Susceptibility


Reference
 
[01]    

Aibinu I. E, Ohaegbulam V. C, Adenipekun E. O, Ogunsola F. T, Odugbemi T. O, Mee B. J. (2003). Extended-Spectrum Beta-Lactamase Enzymes in clinical isolates of Enterobacter species from Lagos, Nigeria. J. Clin. Microbiol; 41: 2197-200.

[02]    

Arzai, A.H. and Adamu, D.J.M. (2008): Prevalence of beta-lactamase Producers among randomly selected bacterial pathogens in Kano, Nigeria. Biological and Environmental Sciences Journal for the Tropics 5 (3):218-223.

[03]    

Asma A, Mohd. I and Firoz A (2014): Determination of multiple antibiotic resistance patternsand indexing among metal tolerant β-lactamase producing Escherichia coli. African Journal of Microbiology Research,8(7): 619-627

[04]    

Bouchillon S.K, Johnson B.M, Hoban D.J, Johnson J.L, Dowzicky M.J, Wu D.H. (2002):Interscience Conference. Antimicrob.Agents Chemother.:42: 27-30.

[05]    

Bush, K., Jacoby, G. A. and Medeiros, A. A. (1995). A Functional Classification Scheme for β- lactamases and its Correlation with Molecular Structure. AntimicrobAgentsChemother. 39:1211-33.

[06]    

Cheesbrough, M. (2006). District Laboratory Practice in Tropical Countries. Cambridge UniversityPress. pp5.

[07]    

Clinical laboratory Standard Institute (2006): Performance standard for antimicrobial susceptibility testing; Approved standard M2-M7, eighteenth informational supplement. CLSI document M100-S18

[08]    

Coque TM, Baquero F, Canton R (2008). Increasing Prevalence of ESBL-producing Enterobacteriaceae in Europe. Eurosur.13: 1-11.

[09]    

Doughari J.H and Akafa M.D (2009): Screening of some Clinical and Environmental samples for β-lactamase producing bacteria. International Journal of Biochemistry. volume 1(35) 1-14

[10]    

Iroha I.R, Amadi, E.S Nwazo A.C and Ejike-ugwu P.C. (2010): Detection of Plasmid borne ESBLs from blood and urine isolates of Gram Negative Bacteria from University Teaching Hospital in Nigeria. Curr Res Bacterial3:77-83.

[11]    

Kiratisin P, Apisarnthanarak A, Laesripa C and Saifon P. (2008): Molecular characterization and epidemiology of extended-spectrum β-lactamase producing Escherichia coli and Klebsiellapnemoniae isolates causing health care-associated infection in Thailand, wherethe CTX-M family is endemic. Antimicrobial Agents of Chemotherapy. 52(8):2818-24.

[12]    

Knothe H, Slah P, Kramery V, Antal M, Mitsuharhi S.(1983) Transferase resistance to cefotaxine, cefoxitin, cefamandole and cefuroxime in chemical isolates of Klebsiellapneumoniae and Serratiamarcescens. Infections; 11(6):315-7.

[13]    

Kotra L.P, Samama J, Mobashery S (2002): β-lactamases and resistance to β-lactam antibiotics. In Bacterial Resistance to Antimicrobials, Lewis K, Salyers AA, Tabar HW, Wax RG (eds). Marcel Decker: New York; 123-160.

[14]    

Muhammad M, Muhammad LU, Ambail AG, Mani AU, (2010): A survey of early chick mortality on small-scale poutry farms in Jos, Central Nigeria. Int. J. Poult.Sci., 9: 446-449

[15]    

O'Callaghan and Cynthia H. (1972): "Novel Method for Detection of B-Lactamases by Using a Chromogenic Cephalosporin Substrate." Antimicrobial Agents and Chemotherapy14: 283-88. 39-41.

[16]    

Osazuwa F and Osazuwa E.O (2011): Detection of ESBLs producing Klebsiella pneumonia and their susceptibility rates to antibiotics in university of Benin Teaching Hospital, Benin City, Nigeria. Research Journal of pharmaceutical, Biological and Chemical Science (RJPBCS). 2(1): 603-605.

[17]    

Parr, T. R., Jr. (1984): "Simple Screening Method for Beta-lactamase-positive and -negative Ampicillin-resistant Haemophilus Influenzae Isolates." Journal of Clinical Microbiology201: 131-32.

[18]    

Paterson D. L., Mulazimoglu, Casellas J. M.(2000): Epidemiology of ciprofloxacin resistance and its relationship to extended spectrum beta-lactamase production in Klebsiella pneumonia isolates causing bacteremia. Clin. Infect. Dis. 30: 473–8.

[19]    

Paterson D.L and Bonomo R.A ( 2005): Extended spectrum β-lactamases: Clinical update. Clin.Microbiol. Rev., 18(4): 657-686.

[20]    

Riaz S., Faisal M and Hasnain S(2012): Prevalence and comparism of β- lactamase producing E. coli and klebsiella species from clinical and Environmental sources in Lahore, Pakistan. African Journal of Microbiology Research, 6 (27): 465-470.

[21]    

Steward C.W, Resheed J.K, Hwert S.K, Biddle J.N, Rancy P.M, Anderson G.J (2001): Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical laboratory Standards for detecting ESBL. J ClinMicrobiol39:2864-71.

[22]    

Yusuf I, Arzai A.H, Umar A, Magaji N, S a l i s u N., Tukur, A. and Haruna, M. (2011): Prevalence of Extended Spectrum ß- Lactamases (ESBL) producing Escherichia coli and Klebsiella pneumoniae in Tuberculosis patients in Kano, Nigeria. Bayero Journal of Pure and Applied Sciences.4(2):182-185.

[23]    

Yusuf, I., Yusha’u, M., Sharif, A.A., Getso, M.I., Yahaya, H., Bala, J.A., Aliyu, I.A. and Haruna, M. (2012): Detection of Metallo beta-lactamases among Gram negative bacterial isolates from Murtala Muhammad Specialist Hospital, Kano and Almadina Hospital Kaduna, Nigeria. Bayero Journal of Pure and Applied Sciences 5(2): 84-89





 
  Join Us
 
  Join as Reviewer
 
  Join Editorial Board
 
share:
 
 
Submission
 
 
Membership